MarketPulse
W

$WGS

4 articles found
1 positive
2 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

ADMA Biologics Plunges 24% After Withdrawing Guidance; Law Firm Eyes Securities Claims

ADMA Biologics shares fell 24% after withdrawing guidance amid channel stuffing allegations. Block & Leviton investigates potential securities violations affecting multiple companies.
WGSWGSWWPRIMADMAsecurities fraudstock decline
The Motley FoolThe Motley Fool··Rick Munarriz

Cathie Wood's ARK Funds Buy the Dip in Shopify, Intellia, GeneDX

ARK Invest added positions in Shopify, Intellia Therapeutics, and GeneDX after significant stock declines, signaling Wood's conviction in long-term potential despite near-term headwinds.
SHOPWGSWGSWWNTLAstock declinegrowth stocks
The Motley FoolThe Motley Fool··Rick Munarriz

Wood's Contrarian Play: Ark Invest Loads Up on Beaten-Down Growth Stocks

Cathie Wood's Ark Invest bought shares of $HOOD, GeneDX, and $TSLA despite steep YTD declines, doubling down on growth bets amid market weakness.
TSLAHOODWGSWGSWWundervalued stocksgrowth stocks
The Motley FoolThe Motley Fool··Rick Munarriz

Cathie Wood's Ark Buys Dip in Flying Taxis, Genetic Testing, Sports Betting

Ark Invest added positions in Joby Aviation, GeneDx Holdings, and DraftKings. All three stocks have fallen significantly but offer growth potential, with Joby announcing White House partnership.
DKNGJOBYJOBY.WSWGSWGSWWeVTOL aircraftemerging technology